Last reviewed · How we verify
NCT03105661
Use of Impedance Cardiography to Decrease the Risk of Pre-eclampsia in Obese Patients
EARLY_PHASE1 trial testing Labetalol Hydrochloride 200 mg in Obesity, Morbid in 400 participants. Status unknown.
31 December 2019
Quick facts
| Lead sponsor | University of Tennessee Graduate School of Medicine |
|---|---|
| Phase | EARLY_PHASE1 |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 400 |
| Start date | 4 April 2017 |
| Primary completion | 31 December 2019 |
| Estimated completion | 4 March 2020 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Labetalol Hydrochloride 200 mg — full drug profile →
- NIFEdipine 60 mg
- Atenolol 25 mg — full drug profile →
Conditions studied
- Obesity, Morbid — all drugs for Obesity, Morbid →
- Preeclampsia — all drugs for Preeclampsia →
Sponsor
University of Tennessee Graduate School of Medicine
Who can join
Adults 18 to 51, female only, with Obesity, Morbid or Preeclampsia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To determine if the use of impedance cardiography can identify appropriate medications for use in treating morbidly obese patients to decrease the risk of preeclampsia.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03105661
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Obesity, Morbid
Currently open trials in the same condition.
- NCT07119437 — Low Impact Laparoscopy In Bariatric Surgery · NA · recruiting
- NCT05927519 — Comparison of Airtraq in Class 2-3 Obese and Nonobese Men During Intubation: a Prospective Randomized Clinical Study · NA · recruiting
- NCT06530212 — Sleeve Gastrectomy With Jejuno-ileal Bypass Versus Single Anastomosis Sleeve Jejunal Bypass · NA · recruiting
- NCT06477120 — Time-restricted Eating Among Pregnant Females With Severe Obesity · NA · recruiting
- NCT06119516 — Transpulmonary Pressure - Guided Mechanical Ventilation in Morbidly Obese ARDS Patients: a Feasibility Study. · NA · recruiting
Other University of Tennessee Graduate School of Medicine trials
Trials by the same sponsor.
- NCT07223437 — REVASC-PAD: REstricted VASCular Exercise for Peripheral Arterial Disease - A Feasibility Study at University of Tennesse · NA · not yet recruiting
- NCT07214012 — Planning Together: A Couple-based, Multi-level Prenatal Contraceptive Education Program for Economically Marginalized Fa · NA · not yet recruiting
- NCT07205068 — Improved Outcomes With Pre-Procedure Shockwave IVL of Common Femoral Artery Access Site Prior to Large Bore Access and P · NA · recruiting
- NCT06953635 — Quadratus Lumborum Versus Placebo in Open Ventral Hernia Repair · NA · not yet recruiting
- NCT07153614 — Efficacy of Perioperative Opioid Sparing Techniques on Time to Initiation of Chemotherapy · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03105661 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Tennessee Graduate School of Medicine
- Last refreshed: 22 February 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03105661.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing